Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.

Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.

Item
http://www.wikidata.org/entity/Q38468990
Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-riskPatients' preferences for bone metastases treatments in France, Germany and the United Kingdom.A descriptive review on methods to prioritize outcomes in a health care context.Concepts of 'personalization' in personalized medicine: implications for economic evaluation.Understanding patient preferences and willingness to pay for hemophilia therapies.Benefit-risk assessment of HMG-CoA reductase inhibitors (statins): a discrete choice experimentQuantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature.Understanding patients' preferences for surgical management of urethral stricture disease.Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?Evaluating migraineurs' preferences for migraine treatment outcomes using a choice experiment.
P2860

Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.

Item
http://www.wikidata.org/entity/Q38468990
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.
@en
type
label
Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.
@en
prefLabel
Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.
@en
P2093
P304
P31
P356
10.1111/J.1524-4733.2010.00694.X
P433
P478
P577
P5875
P698